Bioprinting the law. Paradigm shifts and concerns in supply chain, warranties, liabilities and IP. Ernst-Jan Louwers

Similar documents
eskbook Emerging Life Sciences Companies second edition Chapter 8 Checklist for Planning and Conducting an Effective FTO Search

PATENTS FOR CHEMICALS, PHARMACEUTICALS AND BIOTECHNOLOGY

DRAFT REPORT. EN United in diversity EN. European Parliament 2017/2007(INI)

Dr Lisa Bidwell Research Partnerships Manager, Faculty of Medicine February 2017

The IPR strategies of the Italian National Research Council and its researchers

The TRIPS Agreement and Patentability Criteria

COLLABORATIVE R&D & IP ISSUES IN TECHNOLOGY TRANSFER IN UNIVERSITY SYSTEM

Workshop on International R&D and Technology Transfer Contracts Negotiations, Intellectual Property Rights and Dispute Resolution

The basics of successful IP-Management in Horizon 2020

The Uneasy Future of Software and Business-Method Patents

LAW ON TECHNOLOGY TRANSFER 1998

overblikk Framtidige teknologier et raskt Erik Lehne Managing Partner, Gartner Consulting

TI Designs: Biometric Steering Wheel. Amy Ball TIDA-00292

3D-printing of pharmaceuticals: patent and regulatory challenges

COURSE SCHEDULE

Healthcare and Life Sciences

COMMUNICATION FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT. pursuant to Article 294(6) of the Treaty on the Functioning of the European Union

RECENT DEVELOPMENTS IN THE IMEC IP BUSINESS

Fact Sheet IP specificities in research for the benefit of SMEs

Emerging biotechnologies. Nuffield Council on Bioethics Response from The Royal Academy of Engineering

IT-/IP-Law Intellectual Property Commercial and Corporate Law Labour Law

PERNOD RICARD. Connected Objects: The Experience of Pernod Ricard. Mathieu PROT, Group IP Director

Geoffrey L. Oberhaus Partner

Technology Strategy for Managers and Entrepreneurs

Risky Business: New Compliance Challenges for FDA-Regulated Industry

Low Voltage Brushed Motor System

GZ.:BMWF-8.105/5-II/1/2010

Bloomberg BNA Professional Learning Legal Course Catalog OnDemand Programs

Research Valorization Process.

IP, STRATEGY, PROCEDURE, FTO Peter ten Haaft (PhD, Dutch and European Patent Attorney)

INTELLECTUAL PROPERTY LAW: STRATEGY, AGENCY AND SUPPORT SERVICES

Department of Intellectual Property

Intellectual Property Policy. DNDi POLICIES

The Enterprise Europe Network. in Hungary Zita Majoros, Consultant. Title. Sub-title. 28 th January, Kiev, Ukraine

Quinz Global Law School Life Sciences, R&D and the Law. Closed Workshop Consortium Agreements for R&D Projects in the Life Sciences Sector 3 May 2013

INTELLECTUAL PROPERTY (IP) SME SCOREBOARD 2016

Artificial Intelligence, Business, and the Law

INTELLECTUAL PROPERTY (IP) SME SCOREBOARD 2016

University Technology Transfer, Innovation Ecosystem and EIE Project

Case Study HYDRO-COAT: Duly protecting research project results

The Shape of Things to Come Strategies for Success in the Age of 3D Printing. Husch Blackwell LLP

SAULT COLLEGE OF APPLIED ARTS AND TECHNOLOGY SAULT STE. MARIE, ONTARIO COURSE OUTLINE

Patenting Strategies. The First Steps. Patenting Strategies / Bernhard Nussbaumer, 12/17/2009 1

Committee on Legal Affairs WORKING DOCUMENT

Translation University of Tokyo Intellectual Property Policy

Translational Medicine Symposium 2013: The Roller Coaster Ride to the Clinic

Impact and Innovation in H2020 Proposals and projects

Technology Transfer and Intellectual Property Best Practices

Building a Competitive Edge: Protecting Inventions by Patents and Utility Models

Pharma Session 4: Digital health your health on (the) line

PLANNING YOUR COURSE OF STUDY (JURIS DOCTOR)

Test Report TIDA November 2015

Arlindo Oliveira. An Intellectual Property Strategy supporting Open Innovation

Ethical issues raised by big data and real world evidence projects. Dr Andrew Turner

EXECUTIVE SUMMARY. Investment Opportunity. Paradox Financial Solutions Inc.

INTELLECTUAL PROPERTY OVERVIEW. Patrícia Lima

Question Q 159. The need and possible means of implementing the Convention on Biodiversity into Patent Laws

GDPR Awareness. Kevin Styles. Certified Information Privacy Professional - Europe Member of International Association of Privacy professionals

the SPD company Dr Clive Simon, Principal, The SPD Company.

Anita Pissolito Campos Nascimento & Mourão Advogados. Anita Pissolito Campos Nascimento e Mourão Advogados

RECOMMENDATIONS. COMMISSION RECOMMENDATION (EU) 2018/790 of 25 April 2018 on access to and preservation of scientific information

Engaging Industry Partners

Hackathons as a Source of Entrepreneurship in Corporations

How To Draft Patents For Future Portfolio Growth

Making Identity Use Predictable. UNCITRAL Colloquium on Identity Management and Trust Services 21 April, 2016

The role of Intellectual Property (IP) in R&D-based companies: Setting the context of the relative importance and Management of IP

Non-ferrous metals manufacturing industry: vision for the future and actions needed

The Standardization and the Patent Issue in Telemedicine

Legislative and Regulatory Update. Diane Bowers, CASRO President CASRO Data Collection Conference November 19, 2009

Intellectual Property Importance

Making Decisions - Your Health

François G. Laugier's Representative Experience

Manufuture 2017 Moving up the Value Chain. THE DIGITISATION OF MANUFACTURING Challenges and opportunities for European advanced manufacturing

Public Research and Intellectual Property Rights

Contents. 1 Introduction... 1

Integrating IP Teaching in the Educational System

Intellectual Property /IP/ Research in Business Education

Innovation Office. Intellectual Property at the Nelson Mandela University: A Brief Introduction. Creating value for tomorrow

Licensing, Transfer of Ownership and Dispute Resolution - Commercialization of Intellectual Property Generated in International R&D Projects

University IP and Technology Management. University IP and Technology Management

ESA. European Seed Association. Community Plant Variety Rights System views of the European seed industry

IP Highlights from the article: Knowledge and intellectual property management in customer supplier relationships

Design PMP4489 Test Results

Common evaluation criteria for evaluating proposals

The Shape of Things to Come Strategies for Success in the Age of 3D Printing. Husch Blackwell LLP

THE UNIVERSITY OF AUCKLAND INTELLECTUAL PROPERTY CREATED BY STAFF AND STUDENTS POLICY Organisation & Governance

PROTECTION AND COMMERCIALIZATION OF RESEARCH RESULTS IN CSIC

AIA Continuing Education

Academic Research and Intellectual Property

TIDA Test Report 1/4/2016. TIDA Test Report 1/4/2016

DOC-CAREERS II Project, Final conference Brussels 2012 University-Industry Intellectual property rights: Balancing interests

Intellectual Property

Questionnaire February 2010

A POLICY in REGARDS to INTELLECTUAL PROPERTY. OCTOBER UNIVERSITY for MODERN SCIENCES and ARTS (MSA)

Does your company know about IP rights and use them effectively to achieve business growth and protection?

2015 Primerus Legal Risk Management Seminar: A Comparative Analysis by World Region. Intellectual Property Protecting Your Assets in a Volatile Market

Purvi B. Maniar Member of the Firm

Programs for Academic and. Research Institutions

Best Practice in H2020 Exploitation Management

Characterizing the Variety of Developments Under the Umbrella of 3D Printing

Transcription:

Bioprinting the law Paradigm shifts and concerns in supply chain, warranties, liabilities and IP Ernst-Jan Louwers QED Conference Brussels, 4 November 2014

Who are we? Eindhoven The Hague IP Innovation Privacy Security IT Procurement Internet Ecommerce Anticipate - Advise - Solve Manage risks - Contract Litigate Service - Maintain

Bioprinting: Frankenstein revisited?

By 2016, 3D printing of tissues and organs (bioprinting) will cause a global debate about regulating the technology or banning it for both human and nonhuman use. Gartner 2013

It s not easy Many topics to consider Ownership Compliance R&D Supply chain Body parts or cells Existing regulations* Collaboration Changing rolls Implants Ethics and codes of conduct Background IP and knowhow Relationships Data Fundamental rights Foreground IP and knowhow Risk Intellectual property and secrecy Privacy Valorisation and exploitation Liability * Among others EU Directives and US FDA regulations on admission and classification of medical devices.

What to discuss today? Awareness! Intellectual Property Supply chain Liability Material R&D Risk Method Factory Who? Output Reseller When?

IP main driver: protect it!

Material Method Hardware Software and data Output Your business plan to market

Material patentable?

Starting material patentable? Products of nature: in principle not patentable Isolated human genes? o US: NO, but o AMP/Myriad case o Europe: until now YES o Comparable to plant breeding o Public opinion Nonhuman (synthetic): YES

Methods patentable? Technology of bioprinting: YES Products directly resulting from method? o in principle YES ( product by process )

Hardware

Software, design file and data

Tissue and parts: IP protected? Can you patent an ear? Printed using human cells from Lieuwe van Gogh, great-grandson of Vincent van Gogh (sharing 1/16th of the same genes)

Output: IP protected? Can you patent an ear? Printed human tissue or organs patentable? o function and structure significantly different from human cells o not simply products of nature Inventive step? Novelty? o right ear is same as left ear - no novelty? Output of method: product by process

Protheses and dental

Protheses and dental & IP 3D printed jaw patentable? 3D printed joints patentable? Shape and function? Or only the material? BUT again: Method and output as product by process Mixtures and intermediate result may be patentable

Personalised medicine & IP

Challenge: IP enforcement IP = in principle national law 3D designs easily shared on internet

Supply chain Shift happens Liability

Changing the game Hospitals to become factories Doctors becoming engineers Engineers becoming doctors Dentists printing implants Industry becoming suppliers of human tissue and spares

Rolling the dice Reconsider your position and relationships! Where do you stand in the value chain of the future?

What if something goes terribly wrong?

Risks Contamination Rupture of implant

Product liability Defective products Who is liable? o who is producer? Legislation! o who is responsible? o who is liable? Legislation!

Hospital as reseller Own responsibility? Liability? Warranty? Agreements?

Spare parts and implants Print it yourself protheses? Limited warranty? Product liability? Remove? Recall? Existing regulations and classifications?

Roadmap to market Material Method Hardware Software and data Output Not only business plan But also legal plan

Let s roll the dice: whatever your game is Reconsider Reposition Reorganize Protect Contract Manage

Share (and save) Sharing o best practices o legal insights o policies Agreements o consortium agreements o licenses o R&D

www.louwersadvocaten.nl @louwerslaw @ejlouwers louwers@louwersadvocaten.nl +31 40 2393200 +31 6 52 048154